{"id":199168,"name":"SUN PHARMACEUTICAL INDUSTRIES, INC.","slug":"sun-pharmaceutical-industries-inc","state":"NY","country":"United States of America","description":"Generic Pharmaceutical Company","totalSpending":1920000,"filings":32,"yearlySpending":[{"year":2018,"income":240000},{"year":2019,"income":240000},{"year":2020,"income":240000},{"year":2021,"income":240000},{"year":2022,"income":240000},{"year":2023,"income":240000},{"year":2024,"income":240000},{"year":2025,"income":240000}],"issues":[{"code":"PHA","display":"Pharmacy"}],"firms":["FIERCE GOVERNMENT RELATIONS"],"lobbyists":["WILLIAM BLALOCK","KIRSTEN CHADWICK","MICHAEL CHAPPELL","ALEIX JARVIS","KATE HULL","WILLIAM PIPER","TYLER STEPHENS","ERIC ZULKOSKY"],"govEntities":["SENATE","HOUSE OF REPRESENTATIVES"],"sampleDescriptions":["S. 974- CREATES Act of 2017","S. 974- CREATES Act of 2017, H.R.2212 - CREATES Act of 2017","S. 974- CREATES Act of 2017, H.R.2212 - CREATES Act of 2017, Issues relating to biodefense","H.R. 965- CREATES Act of 2019, S. 340 - CREATES Act of 2019, Issues relating to biodefense, H.R. 1499- Protecting Consumer Access to Generic Drugs Act of 2019","S. 340 - CREATES Act of 2019, Issues relating to biodefense, S. 64 - Preserve Access to Affordable Generics and Biosimilars Act"]}